Indivior PLC
INDV.L·Stocks·Pharmaceuticals Major·United States·LSE·GBP | USD
Price
£24.03
Today
+1.7%
YTD
+93.3%
About
Indivior plc can trace back its history to 1994. This global specialty pharmaceutical company is focused on addiction treatment and develops buprenorphine-based treatments for opioid dependence. Indivior has a portfolio of licenses and patents which enable it to manufacture and market its treatments. In 2017, the company reported a 3% increase in net revenue to $1,093 million. Add this instrument to your watchlist and get the latest updates on INDV.L price movements.
Price chart
Closing price history for INDV.L (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-67.87
P/S (TTM)1.69
P/B (TTM)-7.01
Market cap$1.54B
Cap tierMid-cap
Industry avg P/E-43.29
Profitability
Gross margin83.11%
EBIT margin23.96%
Net margin28.08%
ROE15.32%
ROA18.99%
Earnings & Revenue
Revenue (TTM)$963.51M
Revenue growth (1Y)+5.1%
EPS (TTM)$1.47
Free cash flow$-147.68M
Total debt$385.99M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.09
Employees838
Next earnings31 Jul '25
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.